Repligen Cp (RGEN)
$126.65 2.46 (1.98%)
17:18 EDT RGEN Stock Quote Delayed 30 Minutes
Previous Close $126.65
Market Cap 5.53B
PE Ratio 178.38
Volume (Avg. Vol.) 460,200
Day's Range 124.32 - 127.64
52-Week Range 72.32 - 143.93
Dividend & Yield N/A (N/A)
RGEN Stock Predictions, Articles, and Repligen Cp News
- From InvestorPlace
- From the Web
While many companies were unable to avoid the wrath of the coronavirus pandemic, these three companies stood out as big winners.
Much of the conversation about pharmaceutical stocks rests on the coronavirus, but these high-growth names have potential beyond the pandemic.
Smart beta ETFs typically rebalance every 90 days. The next big rebalance will come in the next few weeks and likely push healthcare stock Repligen (RGEN) higher.
When rumors start buzzing that the government may be about to intervene, then biotech stocks often get slammed...some fairly, and some not (as we’ll see).
Despite the trade dispute with China, these biotech stocks each earn top marks in Portfolio Grader for fundamentals, earnings and momentum.
This morning, I am recommending a bullish trade on Repligen Corporation (NASDAQ:RGEN), the bioprocessing company.
With an aging population, pharma stocks can be a very profitable investments. These 5 biotechs probably aren't.
This week, the overall grades of 37 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
The following stocks were moving the Manufacturing sector today.
This week, 21 Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Healthcare stocks rose broadly on Wall Street on Thursday morning, with the sector seeing an overall increase of 0.3%.
Healthcare stocks rose broadly on Wall Street on Friday, with the sector seeing an overall increase of 0.6%.
Healthcare stocks remained flat on Monday morning on Wall Street.
Healthcare stocks fell on Wall Street on Thursday morning, down 0.3%.
Healthcare stocks finished flat today on Wall Street.
From The Motley Fool
From Market News Video
Investors in Johnson Controls International plc (JCI) saw new options become available today, for the August 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the JCI options chain for the new August 14th contracts and identified one put and one call contract of particular interest.
From Market News Video
Investors in Johnson Controls International plc (JCI) saw new options become available today, for the August 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the JCI options chain for the new August 7th contracts and identified one put and one call contract of particular interest.
Navellier RatingsPowered by Portfolio Grader